http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011203535-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f209ef5eb0bf426bf7278483ca9befc4 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
filingDate | 2011-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_818da2d5e63a858c43a94093fab4bb8a |
publicationDate | 2012-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2011203535-B2 |
titleOfInvention | Survivin peptide vaccine |
abstract | tI'Ud4AUUl Abstract The present invention relates to a therapeutic vaccine comprising one or more survivin 5 polypeptide fragments. The vaccine can be used for prophylactic, ameliorating and/or curative treatment of e.g. cancer diseases. The invention further relates to methods of combination treatment. Fig. 1 zU to a. a, . Fo e CD LO -C~r (9 c'4-- |
priorityDate | 2005-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 714.